aboNT SYRINGE
K-Number: K212677 · 2022-04-15
ApplicantNipro Medical Corporation
Decision Date2022-04-15
Product CodeFMF
Advisory CommitteeHO
DecisionSubstantially Equivalent
Device Summary
aboNT SYRINGE is a medical device manufactured by Nipro Medical Corporation. It received FDA 510(k) clearance on 2022-04-15 under approval number K212677. The device is classified under product code FMF. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the aboNT SYRINGE?
aboNT SYRINGE is a medical device that received FDA 510(k) clearance on 2022-04-15. It is manufactured by Nipro Medical Corporation. The 510(k) number is K212677.
When was aboNT SYRINGE approved by the FDA?
aboNT SYRINGE received FDA 510(k) clearance on 2022-04-15, under approval number K212677.
What company makes aboNT SYRINGE?
aboNT SYRINGE is manufactured by Nipro Medical Corporation.
What is the FDA product code for aboNT SYRINGE?
The FDA product code for aboNT SYRINGE is FMF.
Other Devices by Nipro Medical Corporation
Related Devices (Code: FMF)
K162180Disposable Insulin SyringeBerpu Medical Technology Co., Ltd.
K162081BD 1ml Luer-lok Hypodermic Syringe, BD 1 mL Luer-Lok Hypodermic Syringe with BD Hypodermic Needle or BD Eclipse Hypodermic Needle, BD 1ml Luer-lok Insulin SyringeBecton, Dickinson and Company
K162602NovoPen EchoNovo Nordisk, Inc.
K161568Bone Solutions Mixing and Delivery SystemBone Solutions, Inc.
K152879Sure-Fine Insulin SyringesShina Med Corporation
K160629InPenCompanion Medical, Inc.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.